Kari L. Sutherland
Kari is a former Special Agent with the United States Secret Service. She is a trial attorney and focuses her practice on pharmaceutical and medical device product liability litigation. She has tried cases in various jurisdictions across the country, and her significant pharmaceutical product liability defense verdicts include those resulting from trials in California, Illinois and Louisiana. Kari is recognized by Benchmark Litigation Magazine as one of its Top 250 Female Litigators in America (2016-2018). She also received a 2017 Burton Award and a 2018 Mississippi Defense Lawyers Association “The Quarterly” Editorial Award for her written work.
Kari is a Fellow of the Litigation Counsel of America and a member of the Trial Attorneys of America. She has broad trial experience and has served in key roles, including co-lead trial counsel, in several significant trials. Her trial work includes giving opening statements and closing arguments, cross-examining particularly sympathetic plaintiffs, and skillfully cross-examining nationally-known plaintiff’s experts. She has ample experience directing company witnesses at trial, as well as in defending depositions of company witnesses and other key fact witnesses in underlying litigation.
Her experience includes currently serving as a crucial part of a national counsel team defending prescription medical devices and working as international coordinating counsel. She also serves as a national expert coordinator in pharmaceutical and medical device litigation. She draws on her broad knowledge of FDA regulatory issues in working with experts to defend litigation and in counseling clients on risk avoidance and management strategies. She also works with clients on media responses as part of comprehensive litigation defense strategies.
Kari is active in several industry organizations, including Trial Attorneys of America and Defense Research Institute (DRI). Her speaking engagements include giving a closing argument at DRI’s prestigious Trial Tactics seminar in 2017 and presenting a webinar for FDANews on OTC labeling guidances. She authors articles on litigation and trial-related topics for Butler Snow’s Pro Te: Solutio and other publications such as Law360.
To view Kari’s full firm bio, click here.